Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 25-Jul-22 7:35 PM View:  | Tourmaline Bio, Inc. (TRML) | 25-Jul-22 | Acquisition (other) | 138,500 | -- | -- | 29% 474.67K to 613.17K | |
| 25-Jul-22 7:35 PM View: | Tourmaline Bio, Inc. (TRML) | 25-Jul-22 | Disposition (other) | 138,500 | -- | -- | (23%) 613.17K to 474.67K | |
| 25-Jul-22 7:35 PM View: | Tourmaline Bio, Inc. (TRML) | 21-Jul-22 | Acquisition (other) | 248,432 | -- | -- | 57% 438.17K to 686.6K | |
| 25-Jul-22 7:35 PM View: | Tourmaline Bio, Inc. (TRML) | 21-Jul-22 | Disposition (other) | 248,432 | -- | -- | (34%) 723.1K to 474.67K | |
| 25-Jul-22 7:35 PM View: | Tourmaline Bio, Inc. (TRML) | 21-Jul-22 | Purchase | 36,500 | $3.72 | $135,780.00 | 5% 686.6K to 723.1K | |
| 25-Jul-22 7:35 PM View: | Tourmaline Bio, Inc. (TRML) | 20-Jul-22 | Purchase | 52,000 | $3.62 | $188,240.00 | 13% 386.17K to 438.17K | |
| 25-Jul-22 7:35 PM View: | Tourmaline Bio, Inc. (TRML) | 19-Jul-22 | Private Purchase | 50,000 | $3.52 | $176,000.00 | 15% 336.17K to 386.17K | |
| 12-May-22 4:22 PM View: | Moderna, Inc. (MRNA) | 10-May-22 | Option Exercise | 23,100 | $18.87 | $435,897.00 | 3286% 0.7K to 23.8K | |
| 12-May-22 4:22 PM View: | Moderna, Inc. (MRNA) | 10-May-22 | Option Sale | 3,196 | $136.10 | $434,976.00 | (13%) 23.8K to 20.61K | |
| 02-May-22 4:40 PM View: | Moderna, Inc. (MRNA) | 28-Apr-22 | Option Exercise | 703 | -- | -- | 100% 0 to 0.7K | |
| 16-Dec-21 4:05 PM View: | Tourmaline Bio, Inc. (TRML) | 15-Dec-21 | Gift | 59,520 | -- | -- | (15%) 395.69K to 336.17K | |
| 22-Nov-21 9:06 AM View: | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 6,749 | -- | -- | (100%) 6.75K to 0 | |
| 23-Jul-21 4:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 21-Jul-21 | Disposition | 13,921 | -- | -- | (100%) 13.92K to 0 | |
| 24-May-21 4:30 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 20-May-21 | Grant | 2,635 | -- | -- | 23% 11.29K to 13.92K | |
| 02-Feb-21 6:26 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 1,622 | -- | -- | 32% 5.13K to 6.75K | |
| 26-Jan-21 5:12 PM View: | Prevail Therapeutics Inc. (PRVL) | 22-Jan-21 | Disposition (change in control) | 23,747 | -- | -- | (100%) 23.75K to 0 | |
| 18-May-20 5:14 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 14-May-20 | Grant | 4,409 | -- | -- | 64% 6.88K to 11.29K | |
| 24-Jan-20 5:37 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 1,377 | -- | -- | 37% 3.75K to 5.13K | |
| 25-Jun-19 6:51 PM View: | Prevail Therapeutics Inc. (PRVL) | 24-Jun-19 | Conversion | 23,747 | -- | -- | 100% 0 to 23.75K | |
| 17-May-19 4:37 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 15-May-19 | Grant | 2,726 | -- | -- | 66% 4.15K to 6.88K | |
| 29-Jan-19 5:44 PM View: | Acceleron Pharma Inc (XLRN) | 25-Jan-19 | Grant | 1,250 | -- | -- | 50% 2.5K to 3.75K | |
| 11-May-18 4:12 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-May-18 | Grant | 2,174 | -- | -- | 110% 1.98K to 4.15K | |
| 05-Mar-18 5:18 PM View: | Acceleron Pharma Inc (XLRN) | 01-Mar-18 | Grant | 1,250 | -- | -- | 100% 1.25K to 2.5K | |
| 30-Nov-17 4:12 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Nov-17 | Grant | 1,977 | -- | -- | 100% 0 to 1.98K | |
| 14-Mar-17 6:18 PM View: | Acceleron Pharma Inc (XLRN) | 02-Mar-17 | Grant | 1,250 | -- | -- | 100% 0 to 1.25K | |
| 07-Jun-16 4:27 PM View: | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 7,657 | -- | -- | (100%) 7.66K to 0 | |
| 12-May-16 6:32 PM View: | Baxalta Inc (BXLT) | 10-May-16 | Grant | 4,500 | -- | -- | 143% 3.16K to 7.66K | |
| 29-Jul-15 5:26 PM View: | Baxalta Inc (BXLT) | 27-Jul-15 | Grant | 3,140 | -- | -- | (50%) 6.28K to 3.14K | |
| 24-Feb-15 9:17 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 21-Feb-15 | Disposition (change in control) | 276,955 | $46.00 | $12,739,900.00 | (100%) 276.95K to 0 | |
| 20-Feb-15 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-15 | Payment of Exercise | 12,600 | $45.88 | $578,088.00 | (4%) 289.56K to 276.95K | |
| 20-Feb-15 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-15 | Option Exercise | 24,301 | -- | -- | 9% 265.25K to 289.56K | |
| 20-Feb-15 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Feb-15 | Payment of Exercise | 4,943 | $45.85 | $226,637.00 | (2%) 270.2K to 265.25K | |
| 20-Feb-15 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Feb-15 | Option Exercise | 43,804 | $3.46 | $151,769.00 | 19% 226.39K to 270.2K | |
| 20-Feb-15 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-15 | Payment of Exercise | 7,263 | $45.85 | $333,009.00 | (3%) 233.66K to 226.39K | |
| 20-Feb-15 4:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-15 | Acquisition (other) | 20,301 | -- | -- | 10% 213.35K to 233.66K | |
| 14-Feb-14 9:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-14 | Payment of Exercise | 11,767 | $38.30 | $450,676.00 | (5%) 245.42K to 233.66K | 29% |
| 14-Feb-14 9:47 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-14 | Option Exercise | 24,301 | -- | -- | 11% 221.12K to 245.42K | |
| 11-Feb-14 4:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-14 | Payment of Exercise | 7,258 | $35.13 | $254,974.00 | (3%) 228.38K to 221.12K | 23% |
| 11-Feb-14 4:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-14 | Acquisition (other) | 20,300 | -- | -- | 10% 208.08K to 228.38K | |
| 16-Dec-13 6:18 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Dec-13 | Option Exercise | 139,116 | $5.03 | $699,994.00 | 158% 87.82K to 226.94K | |
| 30-Sep-13 6:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 27-Sep-13 | Option Exercise | 43,458 | $5.94 | $258,019.00 | 49% 87.82K to 131.28K | |
| 30-Sep-13 6:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 27-Sep-13 | Market Option Sale (Planned) | 26,450 | $32.36 | $855,811.00 | (20%) 131.28K to 104.83K | 16% |
| 30-Sep-13 6:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 27-Sep-13 | Market Sale (Planned) | 17,008 | $32.36 | $550,307.00 | (16%) 104.83K to 87.82K | 16% |
| 30-Sep-13 6:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Sep-13 | Option Exercise | 20,342 | $5.09 | $103,521.00 | 9% 217.48K to 237.82K | |
| 30-Sep-13 6:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Sep-13 | Market Option Sale (Planned) | 37,350 | $33.09 | $1,236,020.00 | (16%) 237.82K to 200.47K | 18% |
| 30-Sep-13 6:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Sep-13 | Market Sale (Planned) | 112,650 | $33.09 | $3,727,920.00 | (56%) 200.47K to 87.82K | 18% |
| 10-Apr-13 6:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 10-Apr-13 | Option Exercise | 128,985 | $3.60 | $464,864.00 | 54% 236.86K to 365.85K | |
| 10-Apr-13 6:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 10-Apr-13 | Market Option Sale (Planned) | 128,985 | $11.68 | $1,506,200.00 | (35%) 365.85K to 236.86K | (132%) |
| 10-Apr-13 6:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 10-Apr-13 | Market Sale (Planned) | 19,382 | $11.68 | $226,329.00 | (8%) 236.86K to 217.48K | (132%) |
| 10-Apr-13 6:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 09-Apr-13 | Option Exercise | 150,000 | $4.12 | $617,277.00 | 63% 236.86K to 386.86K |